Keratinocytes suppress transforming growth factor-β1 expression by fibroblasts in cultured skin substitutes
- 1 March 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 140 (3) , 409-416
- https://doi.org/10.1046/j.1365-2133.1999.02700.x
Abstract
Transforming growth factor (TGF)-β1 is a multipotent growth factor with an important role in tissue homeostasis. This growth factor regulates cell proliferation, adhesion, migration and differentiation, as well as extracellular matrix deposition. The temporal secretion and activation of latent TGF-β1 is thus of major importance to physiological and pathological processes and in wound healing and tumour formation. Cultured skin substitutes, as used to treat extensive acute or chronic skin wounds, offer an attractive model to investigate cellular interactions in cytokine and growth factor expression and response in vitro. In the present investigation, expression of TGF-β1 was analysed in keratinocyte, fibroblast and melanocyte monolayer cultures, as well as in the dermal vs. epidermal components of reconstituted human skin. Immunohistology, enzyme-linked immunosorbent assay (ELISA) and Northern blotting were used to demonstrate expression at the RNA and protein level. In the monolayer cultures, levels of TGF-β1 synthesized by melanocytes were observed to be considerably elevated when compared with keratinocytes. Most TGF-β1, however, was secreted by fibroblasts. The relative contribution of the epidermal and dermal components of the skin substitutes to overall TGF-β1 levels was determined by comparing results obtained for either component in the presence and absence of fibroblasts and keratinocytes. From results obtained by ELISA it was apparent that TGF-β1 levels generated predominantly by fibroblasts within the skin substitutes were greatly reduced over time in the presence of keratinocytes. Suppression of fibroblast TGF-β1 expression in the presence of keratinocytes was also demonstrable at the RNA level by Northern blotting. Results obtained by immunohistochemistry suggest that most, if not all, of the growth factor was present in the latent form. It is therefore most likely that the observed effect results from a factor secreted by keratinocytes, which is capable of suppressing TGF-β1 synthesis by fibroblasts. These results suggest that expression of TGF-β1 by fibroblasts is downregulated by paracrine actions of keratinocytes in healing skin.Keywords
This publication has 22 references indexed in Scilit:
- Wound Healing--Aiming for Perfect Skin RegenerationScience, 1997
- Differential Expression of the Calpactin I Subunits Annexin II and p11 in Cultured Keratinocytes and During Wound RepairJournal of Investigative Dermatology, 1997
- Transforming growth factor βs and wound healingThe International Journal of Biochemistry & Cell Biology, 1997
- Latency and activation in the control of TGF-βJournal of Mammary Gland Biology and Neoplasia, 1996
- Skin Repair with Cultured Cells and BiopolymersPublished by Springer Nature ,1996
- TGF-β1 Gene Expression in Cultured Human Keratinocytes Does Not Decrease With Biologic AgeJournal of Investigative Dermatology, 1994
- Transforming growth factor-beta activation in irradiated murine mammary gland.Journal of Clinical Investigation, 1994
- Immunohistological Demonstration of Transforming Growth Factor-β Isoforms in the Skin of Patients with Systemic SclerosisClinical Immunology and Immunopathology, 1993
- Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.Proceedings of the National Academy of Sciences, 1993
- Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cellsNature, 1985